Placebo controlled clinical trial to assess the efficacy and safety of (GOOD NIGHT) after-bite roll-on in reducing mosquito bite induced erythema in Paediatric and adult population

Godrej Consumer Products Pvt Ltd India0 个研究点目标入组 30 人开始时间: 待定最近更新: 2022年10月17日

试验速览

暂无简介。

•Participants of either sex aged more than 3 months of age.
•Participants/parents/guardians who are able to comply with all study requirements with a willingness to participate and give written informed consent(parent/guardian) voluntarily.
•Participants with at least 2 mosquito bites in any part of the arm, leg or face.
•Familiarity with an immediate mosquito bite reaction.
•History of immediately responding to mosquito bites with itching.
•Willing and able to refrain from consuming anti-histamines, corticosteroids, or Non- Steroid Anti-Inflammatory Drugs (NSAID,) for a time period of 1 week prior to the beginning of the study, and continuing throughout the course of the study.
•Willing to abstain from the use of insect repellant and/or any treatment other than the test device for the relief of mosquito bite symptoms until after the study

•Known allergy to compounds of investigational product.
•No history of prior affliction with mosquito bites.
•History of lack of reaction to mosquito and/or other insect bites that includes itching.
•Current use of steroids.
•Use of insect repellants during the week prior to study start.
•Presence of any cardio vascular co morbid conditions.
•Epilepsy or other neurological disorders.
•Severe case of itching or erythema.
•Any skin or other disease or illness that can cause or influence skin itching, such as Psoriasis.
•Participation in research over the preceding 90 days.

发起方

Godrej Consumer Products Pvt Ltd India